|
18.11.2024 22:30:00
|
Publication relating to transparency notifications
REGULATED INFORMATION
Publication relating to transparency notifications
Mont-Saint-Guibert (Belgium), November 18, 2024, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below.
On November 15, 2024, Nyxoah received a transparency notification from ResMed Inc. following the passive crossing of a threshold. Based on the notification, ResMed Inc. holds 1,727,864 voting rights, representing 4.62% of the total number of voting rights on October 9, 2024 (37,389,015).
The notification dated November 5, 2024 contains the following information:
- Reason for the notification: passive crossing of a threshold
- Notification by: a person that notifies alone
- Persons subject to the notification requirement:
- ResMed Inc. (with address at 9001 Spectrum Center Boulevard, San Diego, CA 92123, USA)
- Date on which the threshold was crossed: October 9, 2024
- Threshold that is crossed: 5%
- Denominator: 37,389,015
- Notified details:
| A) Voting rights | Previous notification | After the transaction | |||
|
| # of voting rights | # of voting rights | % of voting rights | ||
| Holders of voting rights |
| Linked to securities | Not linked to the securities | Linked to securities | Not linked to the securities |
| ResMed Inc. | 1,619,756 | 1,727,864 |
|
|
|
|
| TOTAL | 1,727,864 | 0 | 4.62% | 0.00% |
- Full chain of controlled undertakings through which the holding is effectively held: No indirect holding of voting securities. ResMed Inc. is not a controlled entity.
*
* *
Contact:
Nyxoah
John Landry, CFO
IR@nyxoah.com
Attachment
Nachrichten zu Nyxoah S.A. Registered Shs
|
13.12.24 |
EQS-News: Nyxoah gibt die Markteinführung der innovativen Genio®-Therapie in England bekannt (EQS Group) | |
|
13.12.24 |
EQS-News: Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England (EQS Group) | |
|
06.11.24 |
EQS-News: Nyxoah gibt Finanzergebnisse für das dritte Quartal 2024 bekannt und informiert über die Unternehmensentwicklung (EQS Group) | |
|
06.11.24 |
EQS-News: Nyxoah Reports Third Quarter Financial and Operating Results (EQS Group) | |
|
05.11.24 |
EQS-News: Nyxoah kündigt Teilnahme an der Münchner Kapitalmarkt Konferenz und dem Deutschen Eigenkapitalforum an (EQS Group) | |
|
05.11.24 |
Ausblick: Nyxoah mit Zahlen zum abgelaufenen Quartal (finanzen.net) | |
|
21.10.24 |
Erste Schätzungen: Nyxoah öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) | |
|
08.10.24 |
EQS-News: Nyxoah Raises $27 Million through its At-the-Market Offering (EQS Group) |
Analysen zu Nyxoah S.A. Registered Shs
Jahresrückblick & Jahresausblick 2024/2025 – Wall Street Live mit Tim Schäfer
In unserem zweiwöchigen Format „Wall Street Live“ mit Tim Schäfer behandeln wir Topaktuelle Themen des Marktgeschehens.
👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Aktien in diesem Artikel
| Nyxoah S.A. Registered Shs | 8.00 | 0.00% |
|
Meistgelesene Nachrichten
Börse aktuell - Live Ticker
Vorweihnachtliche Zurückhaltung: SMI schlussendlich im Plus -- DAX geht schwächer aus dem HandelDer heimische Aktienmarkt schloss am Montag im Plus, wohingegen sich der deutsche Aktienmarkt abwärts bewegte.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |